EXAGEN INC. 8-K

What Happened

• Exagen Inc. (XGN) filed an 8-K on June 9, 2026 reporting final voting results from its 2026 annual meeting of stockholders held that day.
• Stockholders elected two Class I directors for three-year terms expiring at the 2029 annual meeting: Tina S. Nova, Ph.D. (8,094,349 votes for; 220,954 withheld) and Scott Kahn, Ph.D. (6,295,837 votes for; 2,019,466 withheld). Both elections show 8,663,346 broker non-votes.
• Stockholders ratified BDO USA, P.C. as the company’s independent registered public accounting firm for fiscal 2026 (16,955,368 for; 423,277 against).
• Stockholders approved, by an advisory (non-binding) vote, the compensation of the company’s named executive officers (8,271,156 for; 22,870 against; 21,277 abstentions; 8,663,346 broker non-votes). The matters were described in the company’s definitive proxy statement filed April 27, 2026.

Key Details

• Meeting date: June 9, 2026; proxy statement filed April 27, 2026.
• Director vote totals: Tina S. Nova — 8,094,349 for / 220,954 withheld; Scott Kahn — 6,295,837 for / 2,019,466 withheld.
• Auditor ratification: BDO USA, P.C. — 16,955,368 for / 423,277 against.
• Advisory pay vote: 8,271,156 for / 22,870 against / 21,277 abstentions; 8,663,346 broker non-votes recorded on certain proposals.

Why It Matters

• The elections and ratification confirm the company’s board composition and auditor choice through the stated terms, providing governance continuity.
• The advisory approval of executive compensation signals majority shareholder support (though advisory and non-binding) as disclosed in the proxy.
• The presence of substantial broker non-votes (8,663,346) on several proposals affected the total voting tallies reported and is a notable aspect of the meeting results for investors reviewing shareholder support metrics.